Cancer Research AACR Conference on Molecular Diagnostics - 2008  AACR Conference on Molecular Diagnostics - 2008
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplementary Data
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gupta, P.
Right arrow Articles by Fisher, P. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gupta, P.
Right arrow Articles by Fisher, P. B.
[Cancer Research 66, 8182-8191, August 15, 2006]
© 2006 American Association for Cancer Research


Experimental Therapeutics, Molecular Targets, and Chemical Biology

BiP/GRP78 Is an Intracellular Target for MDA-7/IL-24 Induction of Cancer-Specific Apoptosis

Pankaj Gupta1, Mark R. Walter4, Zao-zhong Su1, Irina V. Lebedeva1, Luni Emdad1, Aaron Randolph5, Kristoffer Valerie5, Devanand Sarkar1 and Paul B. Fisher1,2,3

Departments of 1 Pathology, 2 Neurosurgery, and 3 Urology, Herbert Irving Comprehensive Cancer Center, College of Physicians and Surgeons, Columbia University Medical Center, New York, New York; 4 Department of Microbiology, University of Alabama at Birmingham, Birmingham, Alabama; and 5 Department of Radiation Oncology and Massey Cancer Center, Virginia Commonwealth University, Richmond, Virginia

Requests for reprints: Paul B. Fisher, Departments of Pathology and Urology, College of Physicians and Surgeons, Columbia University Medical Center, BB-1501, 630 West 168th Street, New York, NY 10032. Phone: 212-305-3642; Fax: 212-305-8177; E-mail: pbf1{at}columbia.edu.

Melanoma differentiation-associated gene-7/interleukin-24 (mda-7/IL-24) is a unique member of the IL-10 gene family that induces cancer-selective growth suppression and apoptosis in a wide spectrum of human cancers in cell culture and animal models. Additionally, recent clinical trials confirm safety and document significant clinical activity of mda-7/IL-24 in patients with diverse solid cancers and melanomas. Despite intensive study the molecular basis of tumor-cell selectivity of mda-7/IL-24 is not well characterized. Using deletion analysis, a specific mutant of MDA-7/IL-24, M4, consisting of amino acids 104 to 206, is described that retains the cancer-specific growth-suppressive and apoptosis-inducing properties of the full-length protein. Employing rationally designed mutational analysis, we show that MDA-7/IL-24 and M4 physically interact with BiP/GRP78 through their C and F helices, localize in the endoplasmic reticulum, and activate p38 MAPK and GADD gene expression, culminating in cancer-selective apoptosis. These studies provide novel mechanistic insights into the discriminating antitumor activity of MDA-7/IL-24 by elucidating BiP/GRP78 as a defined intracellular target of action and present an unparalleled opportunity to develop improved therapeutic versions of this cancer-specific apoptosis-inducing cytokine. (Cancer Res 2006; 66(16): 8182-91)




This article has been cited by other articles:


Home page
Proc. Natl. Acad. Sci. USAHome page
M. Sauane, Z.-z. Su, P. Gupta, I. V. Lebedeva, P. Dent, D. Sarkar, and P. B. Fisher
Autocrine regulation of mda-7/IL-24 mediates cancer-specific apoptosis
PNAS, July 15, 2008; 105(28): 9763 - 9768.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
P. Gao, X. Sun, X. Chen, Y. Wang, B. A. Foster, J. Subjeck, P. B. Fisher, and X.-Y. Wang
Secretable Chaperone Grp170 Enhances Therapeutic Activity of a Novel Tumor Suppressor, mda-7/IL-24
Cancer Res., May 15, 2008; 68(10): 3890 - 3898.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
A. Yacoub, M. A. Park, P. Gupta, M. Rahmani, G. Zhang, H. Hamed, D. Hanna, D. Sarkar, I. V. Lebedeva, L. Emdad, et al.
Caspase-, cathepsin-, and PERK-dependent regulation of MDA-7/IL-24-induced cell killing in primary human glioma cells
Mol. Cancer Ther., February 1, 2008; 7(2): 297 - 313.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
A. Yacoub, P. Gupta, M. A. Park, M. Rhamani, H. Hamed, D. Hanna, G. Zhang, D. Sarkar, I. V. Lebedeva, L. Emdad, et al.
Regulation of GST-MDA-7 toxicity in human glioblastoma cells by ERBB1, ERK1/2, PI3K, and JNK1-3 pathway signaling
Mol. Cancer Ther., February 1, 2008; 7(2): 314 - 329.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
M. Sauane, P. Gupta, I. V. Lebedeva, Z.-z. Su, D. Sarkar, A. Randolph, K. Valerie, R. V. Gopalkrishnan, and P. B. Fisher
N-Glycosylation of MDA-7/IL-24 Is Dispensable for Tumor Cell-Specific Apoptosis and "Bystander" Antitumor Activity
Cancer Res., December 15, 2006; 66(24): 11869 - 11877.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2006 by the American Association for Cancer Research.